Speaker illustration

Doctor Michael Farkouh

Cedars-Sinai Health System, Los Angeles (United States of America)

MICHAEL E. FARKOUH, MD, FRCPC, MSc is the Associate Dean, Research at Cedars-Sinai Health System in Los Angeles. Formerly he was the Peter Munk Chair in Multinational Clinical Trials at the Peter Munk Cardiac Centre, and Professor and Vice-Chair, Research, Department of Medicine at the University of Toronto. He is a graduate of the Schulich School of Medicine at Western University. Dr. Farkouh completed his internal medicine and cardiology training at the Mayo Clinic and the Icahn School of Medicine at Mount Sinai New York respectively and holds an MSc in Clinical Epidemiology from McMaster University. Prior to his current appointments, he served as the founding director of the Mount Sinai Cardiovascular Clinical Trials Unit in New York City. Dr. Farkouh has a special interest and expertise in the field of cardiovascular disease in patients with diabetes and has directed the NIH-sponsored FREEDOM and TAILOR-PCI trials.

Blood sugar.

Event: ESC Congress 2019

Topic: European Society of Cardiology, Other

Session: Journal of the American College of Cardiology’s Year in Cardiology: four challenges to enhance major health factors


Lower use of statins among patients with peripheral artery disease compared with those with coronary heart disease

Event: ESC Congress 2019

Topic: Drug therapy

Session: Lipids


Adjudicated cause of death in diabetic patients undegoing coronary revascularization

Event: ESC Congress 2016

Topic: CAD surgery

Session: Best Posters in coronary surgery


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb